BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25519846)

  • 1. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
    Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
    Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
    Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
    Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.
    Belcaro G; Dugall M; Hosoi M; Ippolito E; Cesarone M; Luzzi R; Cornelli U; Ledda A
    Int Angiol; 2014 Feb; 33(1):20-6. PubMed ID: 24452082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
    Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
    Luzzi R; Belcaro G; Ippolito E
    Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in echogenicity of echolucent carotid plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled, randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Bucci M; Dugall M; De Sanctis MT; Incandela L; Griffin M; Sabetai M
    Angiology; 2001 Oct; 52 Suppl 2():S19-25. PubMed ID: 11666118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, randomized, placebo-controlled trial.
    Incandela L; Belcaro G; Nicolaides AN; Cesarone MR; De Sanctis MT; Corsi M; Bavera P; Ippolito E; Griffin M; Geroulakos G; Sabetai M; Ramaswami G; Veller M
    Angiology; 2001 Oct; 52 Suppl 2():S69-73. PubMed ID: 11666127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
    Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
    Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Luzzi R; Hosoi M; Maione C; Cotellese R
    Minerva Cardioangiol; 2019 Dec; 67(6):450-455. PubMed ID: 31850725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
    Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
    Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry.
    Ledda A; Cornelli U; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hu S; Corsi M
    Panminerva Med; 2020 Mar; 62(1):13-18. PubMed ID: 32199407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in Echogenicity in Carotid and Femoral Atherosclerotic Plaques with Pycnogenol + Centella Asiatica Supplementation.
    Belcaro G; Cornelli U
    Int J Angiol; 2017 Jun; 26(2):95-101. PubMed ID: 28566935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
    Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
    Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide.
    Belcaro G; Dugall M; Bradford HD; Cesarone MR; Feragalli B; Gizzi C; Cotellese R; Hu S; Rodriguez P; Hosoi M
    Minerva Cardioangiol; 2019 Apr; 67(2):109-114. PubMed ID: 30964246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of asymptomatic carotid stenosis despite optimal medical therapy.
    Conrad MF; Boulom V; Mukhopadhyay S; Garg A; Patel VI; Cambria RP
    J Vasc Surg; 2013 Jul; 58(1):128-35.e1. PubMed ID: 23806255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    De Sanctis MT; Belcaro G; Incandela L; Cesarone MR; Griffin M; Ippolito E; Cacchio M
    Angiology; 2001 Oct; 52 Suppl 2():S55-9. PubMed ID: 11666125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy.
    Incandela L; Cesarone MR; Cacchio M; De Sanctis MT; Santavenere C; D'Auro MG; Bucci M; Belcaro G
    Angiology; 2001 Oct; 52 Suppl 2():S9-13. PubMed ID: 11666128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.